Tianjin Ringpu Bio-Technology Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 2,224.88 million compared to CNY 2,062.81 million a year ago. Revenue was CNY 2,248.96 million compared to CNY 2,084.25 million a year ago.

Net income was CNY 452.94 million compared to CNY 346.7 million a year ago. Basic earnings per share from continuing operations was CNY 0.9772 compared to CNY 0.7488 a year ago. Diluted earnings per share from continuing operations was CNY 0.9772 compared to CNY 0.7488 a year ago.